STME
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.00 | $0 | -$86,290 |
| 2025 Q2 | -0.01 | $0 | -$74,138 |
| 2025 Q1 | -0.01 | $0 | -$108,142 |
| 2025 Q4 | -0.01 | $0 | -$72,188 |
| 2025 Q3 | -0.01 | $0 | -$29,975 |
| 2024 Q2 | -0.01 | $0 | -$16,519 |
| 2024 Q1 | -0.00 | $0 | -$22,917 |
| 2024 Q4 | -0.00 | $0 | -$30,259 |